DOSSIER · UPDATED 18 JUN 2026

Aura Biosciences

Aura Biosciences is developing a new class of therapies to target and destroy cancer cells selectively, while leaving surrounding tissue unharmed - an approach they call molecular surgery.

aurabiosciences.com ↗Claim this profile

Founded: 2009
Headcount: 93
Open roles: 0
Last raised: Post Ipo Equity · $299M

SECTION I · THE BRIEF

Inside Aura Biosciences

Brief #76355Updated 18 JUN 2026CAMBRIDGEMEDICAL ORGANIZATIONSPOST IPO EQUITY

Employbl Dossier

Aura Biosciences

Aura Biosciences is developing a new class of therapies to target and destroy cancer cells selectively, while leaving surrounding tissue unharmed - an approach they call molecular surgery.

Founded: 2009
Headcount: 93
Open roles: 0
Last raised: Post Ipo Equity · $299M

Section II · Premium ProfileMembers only

01Engineering interview process at Aura BiosciencesLocked
02Tech stack & infrastructure choicesLocked
03Culture & day-to-day work styleLocked
04Why join now vs. 6 months from nowLocked
05Hiring focus & open headcount by teamLocked
06Comp philosophy and band contextLocked

Open Aura Biosciences brief Sign in

7-day free trial · $25/mo · cancel anytime

LEADERSHIP

Founders & key people

John T. Schiller

Elisabet de los Pinos

OPEN ROLES

Hiring at Aura Biosciences

No open roles listed right now. Check back soon or search all jobs →

FUNDING

Capital raised

Total Amount Raised: $755,761,728